» Authors » Haig Inguilizian

Haig Inguilizian

Explore the profile of Haig Inguilizian including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 228
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Kim R, Leal A, Parikh A, Ryan D, Wang S, Bahamon B, et al.
Cancer Chemother Pharmacol . 2023 Feb; 91(4):291-300. PMID: 36738333
Purpose: Guanylyl cyclase C (GCC) is highly expressed in several gastrointestinal malignancies and preclinical studies suggest that it is a promising target for antibody-based therapeutics. This phase I trial assessed...
3.
Wasserstein M, Jones S, Soran H, Diaz G, Lippa N, Thurberg B, et al.
Mol Genet Metab . 2015 Jun; 116(1-2):88-97. PMID: 26049896
Background: Olipudase alfa, a recombinant human acid sphingomyelinase (rhASM), is an investigational enzyme replacement therapy (ERT) for patients with ASM deficiency [ASMD; Niemann-Pick Disease (NPD) A and B]. This open-label...
4.
Monti S, Chapuy B, Takeyama K, Rodig S, Hao Y, Yeda K, et al.
Cancer Cell . 2012 Sep; 22(3):359-72. PMID: 22975378
Diffuse large B cell lymphoma (DLBCL) is a clinically and biologically heterogeneous disease with a high proliferation rate. By integrating copy number data with transcriptional profiles and performing pathway analysis...
5.
Banerji V, Frumm S, Ross K, Li L, Schinzel A, Hahn C, et al.
J Clin Invest . 2012 Feb; 122(3):935-47. PMID: 22326953
Acute myeloid leukemia (AML) is the most common form of acute leukemia in adults. Long-term survival of patients with AML has changed little over the past decade, necessitating the identification...